[Quantitative viremia and p24 antigenemia in short-term follow-up of the treatment with zidovudine in twenty HIV infected patients].
The authors emphasize the interest of detecting HIV p24 antigen after immune complexes dissociation as well as changes in cellular viremia titers in the therapeutic follow-up of HIV infected patients. A significant decline of cell virus titers was found in 4-8 weeks among 13 of 20 zidovudine treated patients. A significant decrease of immune complexes dissociated p24 antigenemia was noted in 11 out of 17 patients.
Tamalet
C
C
Hôpital Timone, bd Jean-Moulin, Marseille, France.
Puel
J
J
Fleury
H
H
Ferchal
F
F
Agut
H
H
Brun-Vezinet
F
F
Botti
G
G
Rouzioux
C
C
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood* / Q000188:drug therapy / Q000276:immunology; D000328:Adult; D000936:Antigen-Antibody Complex / Q000032:analysis; D016655:HIV Core Protein p24 / Q000032:analysis*; D015497:HIV-1 / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D015215:Zidovudine / Q000627:therapeutic use*
D000936:Antigen-Antibody Complex; D016655:HIV Core Protein p24; D015215:Zidovudine
Virémies quantitatives et antigénémies p24 dans le suivi à court terme du traitement par la zidovudine de vingt patients infectés par le VIH.